US Bancorp’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$269K Buy
5,528
+2,465
+80% +$120K ﹤0.01% 1862
2025
Q1
$104K Buy
3,063
+1,854
+153% +$63.1K ﹤0.01% 2373
2024
Q4
$47.6K Sell
1,209
-1,380
-53% -$54.3K ﹤0.01% 2762
2024
Q3
$122K Sell
2,589
-3,228
-55% -$152K ﹤0.01% 2297
2024
Q2
$314K Sell
5,817
-24
-0.4% -$1.3K ﹤0.01% 1764
2024
Q1
$398K Sell
5,841
-8
-0.1% -$545 ﹤0.01% 1633
2023
Q4
$366K Sell
5,849
-494
-8% -$30.9K ﹤0.01% 1680
2023
Q3
$288K Sell
6,343
-452
-7% -$20.5K ﹤0.01% 1655
2023
Q2
$381K Sell
6,795
-755
-10% -$42.4K ﹤0.01% 1523
2023
Q1
$341K Buy
7,550
+659
+10% +$29.8K ﹤0.01% 1610
2022
Q4
$280K Sell
6,891
-6,425
-48% -$261K ﹤0.01% 1680
2022
Q3
$870K Buy
13,316
+4,549
+52% +$297K ﹤0.01% 1119
2022
Q2
$533K Sell
8,767
-759
-8% -$46.1K ﹤0.01% 1405
2022
Q1
$598K Buy
9,526
+866
+10% +$54.4K ﹤0.01% 1450
2021
Q4
$657K Buy
8,660
+1,464
+20% +$111K ﹤0.01% 1402
2021
Q3
$805K Buy
7,196
+1,367
+23% +$153K ﹤0.01% 1303
2021
Q2
$944K Buy
5,829
+599
+11% +$97K ﹤0.01% 1229
2021
Q1
$638K Buy
5,230
+3,973
+316% +$485K ﹤0.01% 1372
2020
Q4
$193K Buy
1,257
+62
+5% +$9.52K ﹤0.01% 1889
2020
Q3
$100K Sell
1,195
-1,100
-48% -$92.1K ﹤0.01% 2075
2020
Q2
$169K Hold
2,295
﹤0.01% 1837
2020
Q1
$97K Buy
2,295
+125
+6% +$5.28K ﹤0.01% 1999
2019
Q4
$132K Buy
2,170
+2,000
+1,176% +$122K ﹤0.01% 2024
2019
Q3
$7K Sell
170
-451
-73% -$18.6K ﹤0.01% 3145
2019
Q2
$29K Buy
621
+526
+554% +$24.6K ﹤0.01% 2747
2019
Q1
$3K Hold
95
﹤0.01% 3338
2018
Q4
$3K Hold
95
﹤0.01% 3312
2018
Q3
$4K Buy
+95
New +$4K ﹤0.01% 3360
2017
Q2
Sell
-39
Closed -$1K 3543
2017
Q1
$1K Buy
+39
New +$1K ﹤0.01% 3453